Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-6-18
|
pubmed:abstractText |
Human immunodeficiency virus type 1 (HIV-1) strains dually resistant to zidovudine and lamivudine (3TC) may arise during zidovudine-3TC combination therapy. The objective of this cross-sectional study (n = 43 patients) was to test the association between therapy response (clinical and immunologic) to zidovudine-3TC and the level of phenotypic zidovudine resistance and zidovudine resistance-associated genotype of 3TC-resistant isolates. Other variables included were baseline CD4+ cell count, baseline Centers for Disease Control and Prevention (CDC) classification, virus load, and time receiving zidovudine. Phenotypic resistance was assessed using a recombinant virus assay. Genotypic analysis was based on population sequencing of plasma HIV-1. In a univariate analysis using a logistic regression model, it was found that therapy response was significantly associated with phenotypic and genotypic zidovudine resistance, baseline CD4+ cell count, and virus load. After adjustment for all variables, phenotypic resistance to zidovudine remained the only significantly associated factor, independent of baseline CD4+ cell count, baseline CDC classification, and virus load.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
177
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1521-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9607829-Anti-HIV Agents,
pubmed-meshheading:9607829-Cross-Sectional Studies,
pubmed-meshheading:9607829-Drug Resistance, Microbial,
pubmed-meshheading:9607829-Drug Resistance, Multiple,
pubmed-meshheading:9607829-Drug Therapy, Combination,
pubmed-meshheading:9607829-Follow-Up Studies,
pubmed-meshheading:9607829-HIV Infections,
pubmed-meshheading:9607829-HIV-1,
pubmed-meshheading:9607829-Humans,
pubmed-meshheading:9607829-Lamivudine,
pubmed-meshheading:9607829-Retrospective Studies,
pubmed-meshheading:9607829-Reverse Transcriptase Inhibitors,
pubmed-meshheading:9607829-Treatment Failure,
pubmed-meshheading:9607829-Zidovudine
|
pubmed:year |
1998
|
pubmed:articleTitle |
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure.
|
pubmed:affiliation |
Zentrum der Inneren Medizin, Klinikum der J.W. Goethe-Universität, Frankfurt, Germany. miller@em.uni-frankfurt.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|